Sonaro addresses the millions that go undiagnosed or misdiagnosed for stroke risk with Vaso3D, a device-agnostic, AI-powered software that converts 2D ultrasound into high-quality 3D vascular imaging transforming 2D ultrasound into AI-driven 3D assessments for fast, reliable stroke risk screening at the point of care.
QuantaPro enables oncologists to determine—early and in real time—whether chemotherapy will work, using a single drop of blood. Beginning with the ERCC1 chemo-resistance test, the company addresses a long-standing clinical blind spot in oncology while building a scalable, high-margin proteomic testing platform that will expand to other chronic diseases.
ReEngage Therapeutics, Inc., is a clinical stage oncology company focused on developing novel treatments for longevity-related diseases, including neurodegeneration and cancer. The company is developing a de-risked molecule, MTB-9655, to treat 3rd line metastatic colorectal cancer.
Viewws is a networked link-in-bio that can orchestrate social media internet traffic at scale. We're transforming link-in-bio pages into a coordinated, monetizable network - connecting creators, brands, and performance at scale. Founders are experienced operators in the creator economy.
Pharma in silica’s precision chemotherapy attacks solid tumors while sparing patients painful, maiming and costly adverse effects imposed by current chemo. OpPacli™ is fifteen months to FDA Phase Ib/IIa 515(b)(2) clinical trial against NSCLC. In 2028, the nanocarrier platform will enable pharmas to capture the chemo drugs US$ 25B market.
Neurava is a strategic and venture backed MedTech company developing a first of its kind AI-powered wearable platform to detect and alert for convulsive seizures as well as any induced cardio-respiratory dysfunctions, to stratify high risk patients and help prevent SUDEP. The company will be FDA cleared and on the market in 2026 with an experienced commercial team and board, including the former chairman of LivaNova.
Sugarfina is an international luxury candy brand that blends high-quality confections with a fun, modern aesthetic. The principals have invested $21M of their own capital, demonstrating strong conviction and alignment with long-term value creation. Powered by a seasoned leadership and management team with a proven track record of building, scaling, and successfully exiting consumer brands and rollups, Sugarfina is built to win. The company is executing an omni-channel premium brand roll-up across premium gifting, confectionery, and beverage categories, with significant growth opportunities ahead, including actionable M&A targets.
Holograms are objects that appear to float in the air and look real, but are created using laser light. Axiom has developed a new type of hologram technology and was awarded Time Magazine’s Best Technology of 2023. Customers include Lockheed Martin, Honeywell, Bentley, and others. Axiom also operates a hologram entertainment division and is opening Hologram Zoo franchises across the U.S., where all animals are created entirely from laser light.
Axiom creates a new type of Hologram Technology. Holograms are objects that float in the air and look real, but they are made out of laser light. They were awarded Time Magazines best technology 2023. Customers include Lockheed, Honeywell, Bentley, and many others. The Company also has a hologram entertainment division, They are opening Hologram Zoo franchise in the US where all the animals are made of laser light.